<?xml version="1.0" ?>
<document id="222534164391422210b3089109605e8ff4d1d46c">
  <chunk id="222534164391422210b3089109605e8ff4d1d46c.c0" text="SARS coronavirus papain-like protease induces Egr-1-dependent up-regulation of TGF-β1 via ROS/ p38 MAPK/STAT3 pathway OPEN">
    <entity charOffset="0-4" id="222534164391422210b3089109605e8ff4d1d46c.c0.e0" ontology_id="DOID_2945" text="SARS" type="disease"/>
    <entity charOffset="110-117" id="222534164391422210b3089109605e8ff4d1d46c.c0.e1" ontology_id="CHEBI_34922" text="pathway" type="chemical"/>
    <pair e1="222534164391422210b3089109605e8ff4d1d46c.c0.e0" e2="222534164391422210b3089109605e8ff4d1d46c.c0.e1" id="222534164391422210b3089109605e8ff4d1d46c.c0.p0" relation="true"/>
  </chunk>
  <chunk id="222534164391422210b3089109605e8ff4d1d46c.c1" text="cells. Dual luciferase reporter assays with TGF-β1 promoter plasmids indicated that TGF-β1 promoter region between −175 to −60, the Egr-1 binding site, was responsible for TGF-β1 promoter activation induced by SARS-CoV PLpro. Subcellular localization analysis of transcription factors showed PLpro triggering nuclear translocation of Egr-1, but not NF-κB and Sp-1. Meanwhile, Egr-1 silencing by siRNA significantly reduced PLpro-induced up-regulation of TGF-β1, TSP-1 and pro-fibrotic genes. Furthermore, the inhibitors for ROS (YCG063), p38 MAPK (SB203580), and STAT3 (Stattic) revealed ROS/p38 MAPK/STAT3 pathway involving in Egr-1 dependent activation of TGF-β1 promoter induced by PLpro. In a mouse model with a direct pulmonary injection, PLpro stimulated macrophage infiltration into lung, up-regulating Egr-1, TSP-1, TGF-β1 and vimentin expression in lung tissues. The results revealed that SARS-CoV PLpro significantly triggered Egr-1 dependent activation of TGF-β1 promoter via ROS/p38 MAPK/STAT3 pathway, correlating with up-regulation of pro-fibrotic responses in vitro and in vivo.">
    <entity charOffset="509-519" id="222534164391422210b3089109605e8ff4d1d46c.c1.e0" ontology_id="CHEBI_35222" text="inhibitors" type="chemical"/>
    <entity charOffset="524-527" id="222534164391422210b3089109605e8ff4d1d46c.c1.e1" ontology_id="CHEBI_26523" text="ROS" type="chemical"/>
    <entity charOffset="570-577" id="222534164391422210b3089109605e8ff4d1d46c.c1.e2" ontology_id="CHEBI_86989" text="Stattic" type="chemical"/>
    <entity charOffset="588-591" id="222534164391422210b3089109605e8ff4d1d46c.c1.e3" ontology_id="CHEBI_26523" text="ROS" type="chemical"/>
    <entity charOffset="607-614" id="222534164391422210b3089109605e8ff4d1d46c.c1.e4" ontology_id="CHEBI_34922" text="pathway" type="chemical"/>
    <entity charOffset="987-990" id="222534164391422210b3089109605e8ff4d1d46c.c1.e5" ontology_id="CHEBI_26523" text="ROS" type="chemical"/>
    <entity charOffset="1006-1013" id="222534164391422210b3089109605e8ff4d1d46c.c1.e6" ontology_id="CHEBI_34922" text="pathway" type="chemical"/>
  </chunk>
  <chunk id="222534164391422210b3089109605e8ff4d1d46c.c2" text="Severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) is the causative agent of SARS outbreak in 2003 1,2 . SARS-CoV infection induces severe respiratory illnesses, such as bronchial epithelial denudation, loss of cilia, multinucleated syncytial cells, squamous metaplasia and transendothelial migration of monocytes/macrophages and neutrophils into lung tissue 3,4 . SARS-CoV triggers a pro-inflammatory cytokine storm that links with pulmonary fibrosis of SARS patients 5,6 . Near 20% of SARS patients recovered still have lung fibrosis 9 months post infection 7,8 .">
    <entity charOffset="0-33" id="222534164391422210b3089109605e8ff4d1d46c.c2.e0" ontology_id="DOID_2945" text="Severe acute respiratory syndrome" type="disease"/>
    <entity charOffset="25-33" id="222534164391422210b3089109605e8ff4d1d46c.c2.e1" ontology_id="DOID_225" text="syndrome" type="disease"/>
    <entity charOffset="101-105" id="222534164391422210b3089109605e8ff4d1d46c.c2.e2" ontology_id="DOID_2945" text="SARS" type="disease"/>
    <entity charOffset="129-147" id="222534164391422210b3089109605e8ff4d1d46c.c2.e3" ontology_id="DOID_2945" text="SARS-CoV infection" type="disease"/>
    <entity charOffset="457-475" id="222534164391422210b3089109605e8ff4d1d46c.c2.e4" ontology_id="DOID_3770" text="pulmonary fibrosis" type="disease"/>
    <entity charOffset="479-483" id="222534164391422210b3089109605e8ff4d1d46c.c2.e5" ontology_id="DOID_2945" text="SARS" type="disease"/>
    <entity charOffset="511-515" id="222534164391422210b3089109605e8ff4d1d46c.c2.e6" ontology_id="DOID_2945" text="SARS" type="disease"/>
  </chunk>
  <chunk id="222534164391422210b3089109605e8ff4d1d46c.c3" text="SARS-CoV contains a single stranded and positive sense RNA genome that has a 5′ cap and a 3′ poly-(A) tract containing 14 open reading frames (ORFs) 1,2 . ORF1a and ORF1ab at the 5′ proximal end encode two large overlapping replicase polyproteins 1a and 1ab (~450 and ~750 kDa, respectively). Two specific embedded proteases, papain-like (PLpro) and 3C-like (3CLpro), mediate the proteolytic processing of polyproteins 1a and 1ab precursors into 16 nsps (termed nsp1-16). SARS-CoV PLpro is identified as a deubiquitinating enzyme that removes Lys48-linked polyubiquitin chains 9 . PLpro blocks polyI:C-induced activation of IRF3, NF-κ B, and STAT1, correlating with the inhibitory effect on interferon (IFN) induction and signaling 10 . Recent, SARS-CoV PLpro exhibits the deubiquitinating enzymatic activity on RIG-I, STING, TRAF3, TBK1, and IRF3, in which suppresses STING-TRAF3-TBK1 signaling pathway, then negatively regulating IRF3 activation 11 . Our laboratory demonstrates type I IFN antagonist mechanism of SARS-CoV PLpro correlating with the activation of ubiquitin-proteosome pathway, in which inhibits type I IFN-induced phosphorylation of STAT1 Ser727">
    <entity charOffset="55-58" id="222534164391422210b3089109605e8ff4d1d46c.c3.e0" ontology_id="CHEBI_33697" text="RNA" type="chemical"/>
    <entity charOffset="691-701" id="222534164391422210b3089109605e8ff4d1d46c.c3.e1" ontology_id="CHEBI_52999" text="interferon" type="chemical"/>
    <entity charOffset="992-1002" id="222534164391422210b3089109605e8ff4d1d46c.c3.e2" ontology_id="CHEBI_48706" text="antagonist" type="chemical"/>
  </chunk>
</document>
